Revvity, Inc.

DB:PKN Stock Report

Market Cap: €13.1b

Revvity Past Earnings Performance

Past criteria checks 3/6

Revvity's earnings have been declining at an average annual rate of -10.9%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been declining at an average rate of 2.7% per year. Revvity's return on equity is 3.3%, and it has net margins of 9.5%.

Key information

-10.9%

Earnings growth rate

-13.0%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate-2.7%
Return on equity3.3%
Net Margin9.5%
Last Earnings Update29 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Revvity makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:PKN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
29 Sep 242,722258949199
30 Jun 242,708197942202
31 Mar 242,726183943211
31 Dec 232,751180942217
01 Oct 232,796213898222
02 Jul 232,837250903222
02 Apr 233,024353918221
01 Jan 233,312513940222
02 Oct 223,5995991,001222
03 Jul 223,748637989219
03 Apr 223,483694885195
02 Jan 223,828889854200
03 Oct 214,1551,086893197
04 Jul 214,2571,155893197
04 Apr 214,4381,074961217
03 Jan 212,663631729146
04 Oct 203,234412887196
05 Jul 202,977294866191
05 Apr 202,887226845190
29 Dec 192,884228833189
29 Sep 192,835235806194
30 Jun 192,802251794197
31 Mar 192,783247790196
30 Dec 182,778237809194
30 Sep 182,663128761180
01 Jul 182,543149719166
01 Apr 182,387147667152
31 Dec 172,257157615139
01 Oct 172,182258587135
02 Jul 172,142215580129
02 Apr 172,132210584128
01 Jan 172,116216585124
02 Oct 161,999198574108
03 Jul 162,048199583110
03 Apr 162,076190583110
03 Jan 162,105189586113
04 Oct 152,263176661127
28 Jun 152,241164657126
29 Mar 152,234167656124
28 Dec 142,070130648108
28 Sep 142,221203576123
29 Jun 142,201201577124
30 Mar 142,185176579128
29 Dec 132,158174581132

Quality Earnings: PKN has a large one-off loss of $105.6M impacting its last 12 months of financial results to 29th September, 2024.

Growing Profit Margin: PKN's current net profit margins (9.5%) are higher than last year (7.7%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: PKN's earnings have declined by 10.9% per year over the past 5 years.

Accelerating Growth: PKN's earnings growth over the past year (20.5%) exceeds its 5-year average (-10.9% per year).

Earnings vs Industry: PKN earnings growth over the past year (20.5%) exceeded the Life Sciences industry -1.4%.

Return on Equity

High ROE: PKN's Return on Equity (3.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 07:59
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/29
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Revvity, Inc. is covered by 43 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Ishan MajumdarBaptista Research
Luke SergottBarclays